182 related articles for article (PubMed ID: 15932521)
1. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
Arason GJ; Kolka R; Hreidarsson AB; Gudjonsson H; Schneider PM; Fry L; Arnason A
Clin Exp Immunol; 2005 Jun; 140(3):572-9. PubMed ID: 15932521
[TBL] [Abstract][Full Text] [Related]
2. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
3. [The association of complement with common connective tissue diseases - a review].
Arason GJ
Laeknabladid; 2008 May; 94(5):371-4. PubMed ID: 18460733
[TBL] [Abstract][Full Text] [Related]
4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis.
Arason GJ; Geirsson AJ; Kolka R; Víkingsdóttir T; Valdimarsson H
Ann Rheum Dis; 2002 Mar; 61(3):257-60. PubMed ID: 11830434
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
9. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.
Ittiprasert W; Kantachuvesiri S; Pavasuthipaisit K; Verasertniyom O; Chaomthum L; Totemchokchyakarn K; Kitiyanant Y
J Autoimmun; 2005 Aug; 25(1):77-84. PubMed ID: 15998580
[TBL] [Abstract][Full Text] [Related]
10. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
11. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
12. Inherited deficiency of the fourth component of human complement.
Hauptmann G; Tappeiner G; Schifferli JA
Immunodefic Rev; 1988; 1(1):3-22. PubMed ID: 3078708
[TBL] [Abstract][Full Text] [Related]
13. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
Gatenby PA; Barbosa JE; Lachmann PJ
Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
[TBL] [Abstract][Full Text] [Related]
14. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
15. The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
Holme ER; Veitch J; Johnston A; McKay IC; Whaley K
Rheumatol Int; 1992; 12(5):187-90. PubMed ID: 1290020
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
18. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
